Brooks Houghton Investment Banking

WeWork delays IPO after frosty investor response

WeWork owner The We Company has postponed its initial public offering (IPO), walking away from preparations to launch it this month after a lackluster response from investors to its plans.

Read More

Oxycontin maker Purdue begins bankruptcy in push to settle opioid lawsuits

OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the

Read More

Saudi Aramco pursues IPO planning despite attack damage doubts

Saudi Aramco is pressing ahead with its listing plans this week, although some investors and analysts doubt it can now meet its timeline as it has not said when oil

Read More

Kevin M. Halpin joins Brooks, Houghton & Company, Inc. - July 31, 2019

New York, NY Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that Kevin M. Halpin has joined the firms Investment Banking team as a Managing Director.

Read More
BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Final Tranche Acquisition - November 5, 2018

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the second and final tranche acquisition of remaining operating assets

Read More
BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Acquisition of Assets - October 11, 2018

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto

Read More

Sale of Specialty Packaging Manufacturer

Purchase of an Office Products Company

Senior and Junior Debt Raise for a Steel Products Company

Lease Financing for the Subsidiary of an Aluminum Company

Equity Raise for a Luxury Hotel and Spa